129 related articles for article (PubMed ID: 24248547)
21. Receptor for advanced glycation end products (RAGE) polymorphisms are associated with systemic lupus erythematosus and disease severity in lupus nephritis.
Martens HA; Nienhuis HL; Gross S; van der Steege G; Brouwer E; Berden JH; de Sévaux RG; Derksen RH; Voskuyl AE; Berger SP; Navis GJ; Nolte IM; Kallenberg CG; Bijl M
Lupus; 2012 Aug; 21(9):959-68. PubMed ID: 22513366
[TBL] [Abstract][Full Text] [Related]
22. Association of polymorphisms of the receptor for advanced glycation end products gene with COPD in the Chinese population.
Li Y; Yang C; Ma G; Gu X; Chen M; Chen Y; Zhao B; Cui L; Li K
DNA Cell Biol; 2014 Apr; 33(4):251-8. PubMed ID: 24520905
[TBL] [Abstract][Full Text] [Related]
23. A meta-analysis of receptor for advanced glycation end products gene: four well-evaluated polymorphisms with diabetes mellitus.
Niu W; Qi Y; Wu Z; Liu Y; Zhu D; Jin W
Mol Cell Endocrinol; 2012 Jul; 358(1):9-17. PubMed ID: 22402134
[TBL] [Abstract][Full Text] [Related]
24. Possible pathologic involvement of receptor for advanced glycation end products (RAGE) for development of encapsulating peritoneal sclerosis in Japanese CAPD patients.
Numata M; Nakayama M; Hosoya T; Hoff CM; Holmes CJ; Schalling M; Nordfors L; Lindholm B
Clin Nephrol; 2004 Dec; 62(6):455-60. PubMed ID: 15630905
[TBL] [Abstract][Full Text] [Related]
25. Receptor for advanced glycation end products (RAGE)--soluble form (sRAGE) and gene polymorphisms in patients with breast cancer.
Tesarová P; Kalousová M; Jáchymová M; Mestek O; Petruzelka L; Zima T
Cancer Invest; 2007 Dec; 25(8):720-5. PubMed ID: 18058469
[TBL] [Abstract][Full Text] [Related]
26. The Gly82Ser polymorphism of the receptor of advanced glycation end product (RAGE) gene is not associated with type 1 or type 2 diabetes in a Brazilian population.
Naka CL; Picheth G; Alcântera VM; Réa RR; Chautard-Freire-Maia EA; Pedrosa Fde O; Martinez TL; Souza EM
Diabetes Care; 2006 Mar; 29(3):712-3. PubMed ID: 16505535
[No Abstract] [Full Text] [Related]
27. Association between the receptor for advanced glycation end products gene polymorphisms and cancer risk: a systematic review and meta-analysis.
Zhao DC; Lu HW; Huang ZH
J BUON; 2015; 20(2):614-24. PubMed ID: 26011358
[TBL] [Abstract][Full Text] [Related]
28. Genetic predisposition to advanced glycation end products toxicity is related to prognosis of chronic hemodialysis patients.
Kalousová M; Jáchymová M; Germanová A; Kubena AA; Tesar V; Zima T
Kidney Blood Press Res; 2010; 33(1):30-6. PubMed ID: 20185929
[TBL] [Abstract][Full Text] [Related]
29. RAGE polymorphisms and the heritability of insulin resistance: the Leeds family study.
Sullivan CM; Futers TS; Barrett JH; Hudson BI; Freeman MS; Grant PJ
Diab Vasc Dis Res; 2005 Feb; 2(1):42-4. PubMed ID: 16305072
[TBL] [Abstract][Full Text] [Related]
30. Soluble receptor for advanced glycation end-products (sRAGE) and polymorphisms of RAGE and glyoxalase I genes in patients with pancreas cancer.
Krechler T; Jáchymová M; Mestek O; Zák A; Zima T; Kalousová M
Clin Biochem; 2010 Jul; 43(10-11):882-6. PubMed ID: 20398646
[TBL] [Abstract][Full Text] [Related]
31. Gene polymorphisms (G82S, 1704G/T, 2184A/G and 2245G/A) of the receptor of advanced glycation end products (RAGE) in plaque psoriasis.
Vasků V; Kanková K; Vasků A; Muzík J; Izakovicová Hollá L; Semrádová V; Vácha J
Arch Dermatol Res; 2002 May; 294(3):127-30. PubMed ID: 12029499
[TBL] [Abstract][Full Text] [Related]
32. Gly82Ser polymorphism of the receptor of advanced glycation end product gene is not associated with coronary heart disease in Finnish nondiabetic subjects or in patients with type 2 diabetes.
Pulkkinen A; Viitanen L; Kareinen A; Lehto S; Laakso M
Diabetes Care; 2000 Jun; 23(6):864. PubMed ID: 10841016
[No Abstract] [Full Text] [Related]
33. Receptor for advanced glycation end-product (RAGE) gene polymorphism 2245G/A is associated with pro-inflammatory, oxidative-glycation markers and sRAGE in diabetic retinopathy.
Ng ZX; Kuppusamy UR; Iqbal T; Chua KH
Gene; 2013 Jun; 521(2):227-33. PubMed ID: 23545311
[TBL] [Abstract][Full Text] [Related]
34. Clinical significance of AGE-RAGE axis in colorectal cancer: associations with glyoxalase-I, adiponectin receptor expression and prognosis.
Sakellariou S; Fragkou P; Levidou G; Gargalionis AN; Piperi C; Dalagiorgou G; Adamopoulos C; Saetta A; Agrogiannis G; Theohari I; Sougioultzis S; Tsioli P; Karavokyros I; Tsavaris N; Kostakis ID; Zizi-Serbetzoglou A; Vandoros GP; Patsouris E; Korkolopoulou P
BMC Cancer; 2016 Mar; 16():174. PubMed ID: 26931562
[TBL] [Abstract][Full Text] [Related]
35. Association of
Hu D; Liu Q; Lin X; Zhang H; Lin J; Zheng X; Peng F
J Cancer; 2019; 10(2):504-509. PubMed ID: 30719146
[No Abstract] [Full Text] [Related]
36. Association of 1704G/T and G82S polymorphisms in the receptor for advanced glycation end products gene with diabetic retinopathy in Chinese population.
Zhang HM; Chen LL; Wang L; Liao YF; Wu ZH; Ye F; Xu S; Yi LL
J Endocrinol Invest; 2009 Mar; 32(3):258-62. PubMed ID: 19542745
[TBL] [Abstract][Full Text] [Related]
37. APOE ε4 Carriers Have a Greater Propensity to Glycation and sRAGE Which Is Further Influenced by RAGE G82S Polymorphism.
Deo P; Dhillon VS; Chua A; Thomas P; Fenech M
J Gerontol A Biol Sci Med Sci; 2020 Sep; 75(10):1899-1905. PubMed ID: 31677348
[TBL] [Abstract][Full Text] [Related]
38. RAGE polymorphisms, renal function and histological finding at 12 months after renal transplantation.
Kalousová M; Brabcová I; Germanová A; Jáchymová M; Matl I; Mestek O; Bandúr S; Zima T; Viklický O
Clin Biochem; 2009 Mar; 42(4-5):347-52. PubMed ID: 19133252
[TBL] [Abstract][Full Text] [Related]
39. Association of four genetic polymorphisms of AGER and its circulating forms with coronary artery disease: a meta-analysis.
Peng F; Hu D; Jia N; Li X; Li Y; Chu S; Zhu D; Shen W; Lin J; Niu W
PLoS One; 2013; 8(7):e70834. PubMed ID: 23894685
[TBL] [Abstract][Full Text] [Related]
40. A prospective study of soluble receptor for advanced glycation end-products and colorectal cancer risk in postmenopausal women.
Chen L; Duan Z; Tinker L; Sangi-Haghpeykar H; Strickler H; Ho GY; Gunter MJ; Rohan T; Logsdon C; White DL; Royse K; El-Serag HB; Jiao L
Cancer Epidemiol; 2016 Jun; 42():115-23. PubMed ID: 27100837
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
